Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives.

Expert opinion on therapeutic targets - 1 Dec 2024

Yan Xing Yi, Kang Yuan Yuan, Zhang Ze Yan, Huang Ping, Yang Chang, Naranmandura Hua

Abstract excerpt

INTRODUCTION: Leukemia is typically categorized into myeloid leukemia and lymphoblastic leukemia based on the origins of leukemic cells. Myeloid leukemia is a group of clonal malignancies characterized by the presence of increased immature myeloid cells in both the bone marrow and peripheral blood. Of note, the aberrant expression of specific proteins or the generation of fusion proteins due to chromosomal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Development

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gene Editing

Share to Leukemia, Myeloid

Share to Molecular Targeted Therapy

Share to Oncogene Proteins

Share to Prognosis

Source

Identifiers

PMID: 39679536
DOI: 10.1080/14728222.2024.2443577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives.PMID 39679536Read ↗

Clinical and molecular consequences of fusion genes in myeloid malignanciesSemantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Myeloid malignancies: mutations, models and management.Semantic proximity Read ↗

A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growthSemantic proximity Read ↗

The molecular pathology of acute myeloid leukemia.Semantic proximity Read ↗

Gene Mutations and Targeted Therapies of Myeloid Sarcoma.Semantic proximity Read ↗

Novel therapies in AML: reason for hope or just hype?Semantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and ClinicalSemantic proximity Read ↗

An overview of novel therapies in advanced clinical testing for acute myeloid leukemia.Semantic proximity Read ↗

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.